Cipla Ltd. — Regulatory Filings 2021

Jun 29, 2021

29[th] June 2021

(1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087 Scrip Code: CIPLA EQ

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Response to media query

Dear Sir/Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit that in response to media queries on vaccine import, the Company would be releasing the following statement:

"Cipla Limited is supporting Moderna, Inc. with the regulatory approval and importation of vaccines to be donated to India. At this stage, there is no definitive agreement on commercial supplies.”

Please take the above information on record.

Thanking you,

Yours faithfully, For Cipla Limited RAJENDR Digitally signed by RAJENDRA A CHOPRA Date: 2021.06.29 CHOPRA 20:17:30 +05'30' Rajendra Chopra Company Secretary

Prepared by: Mandar Kurghode